IMNN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
2.8M
-35.2%
4.3M
+1.1%
4.3M
+22.6%
3.5M
+25.6%
2.8M
R&D
1.5M
-37.3%
2.3M
-6.1%
2.5M
+31.1%
1.9M
+54.8%
1.2M
SG&A
1.3M
-32.6%
2.0M
+11.1%
1.8M
+12.4%
1.6M
+2.3%
1.5M
Operating Income
-2791546
+35.2%
-4306552
-1.1%
-4261703
-22.6%
-3475828
-25.6%
-2767864
EBITDA
-2721546
+35.8%
-4236552
-1.2%
-4186625
-23.1%
-3400688
-26.3%
-2692855
Net Income
-2814114
+33.8%
-4249022
-0.6%
-4222850
-23.1%
-3429124
-25.1%
-2740559
EPS (Basic)
$-0.54
+35.7%
$-0.84
+40.8%
$-1.42
-22.4%
$-1.16
+46.0%
$-2.15
EPS (Diluted)
$-0.54
+35.7%
$-0.84
+40.8%
$-1.42
-22.4%
$-1.16
+46.0%
$-2.15
Shares (Diluted)
5.2M
+4.1%
5.0M
+69.2%
3.0M
+0.9%
2.9M
+130.5%
1.3M
Imunon (IMNN) โ€” Financials